chr2-178747278-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_133379.5(TTN):c.15122C>G(p.Thr5041Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000365 in 1,613,128 control chromosomes in the GnomAD database, with no homozygous occurrence. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_133379.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_133379.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | TSL:5 MANE Select | c.11312-5357C>G | intron | N/A | ENSP00000467141.1 | Q8WZ42-12 | |||
| TTN | TSL:1 | c.11312-5357C>G | intron | N/A | ENSP00000408004.2 | A0A1B0GXE3 | |||
| TTN | TSL:1 | c.11036-5357C>G | intron | N/A | ENSP00000405517.2 | A0A0C4DG59 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 151954Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000160 AC: 40AN: 250254 AF XY: 0.000148 show subpopulations
GnomAD4 exome AF: 0.000387 AC: 565AN: 1461174Hom.: 0 Cov.: 34 AF XY: 0.000365 AC XY: 265AN XY: 726898 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000151 AC: 23AN: 151954Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74204 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.